Banner - NPPA Connect
News|Articles|September 18, 2026

Maui Derm NP+PA Fall 2026 Day 1: New Therapies, Cutaneous Oncology, and Clinical Pearls

Listen
0:00 / 0:00

Key Takeaways

  • A year-in-review format synthesized impactful dermatology publications across journals, prioritizing clinically actionable findings relevant to 2026 practice patterns.
  • Forward-looking therapy discussions outlined newer agents and practical positioning strategies, emphasizing how to integrate emerging options into routine management algorithms.
SHOW MORE

Day 1 of Maui Derm NP+PA Fall 2026 highlighted emerging therapies, cutaneous oncology, challenging dermatitis cases, and procedural pearls.

Maui Derm NP+PA Fall 2026 kicked off September 16 at The Greenbrier in White Sulphur Springs, West Virginia, with a full day of clinical education spanning noteworthy dermatology literature, emerging therapies, cutaneous oncology, eczematous and contact dermatitis, and procedural dermatology.

Throughout the opening day, faculty paired updates on the evolving dermatology treatment landscape with interactive cases and practical strategies aimed at helping nurse practitioners (NPs) and physician assistants (PAs) translate new evidence into clinical practice.

Looking Back at a Year of Dermatology Research

The scientific program began with “Literature from 2026 in Review,” featuring Ted Rosen, MD; Vikash Oza, MD; Matthew Zirwas, MD; and Douglas DiRuggiero, DMSc, MSPAS, PA-C. Faculty reviewed noteworthy articles published across a range of dermatology journals over the past year.

The morning then shifted from recently published evidence to what lies ahead. During New Products and New Therapies, Rosen and George Martin, MD, discussed newer drugs and therapeutic options and how clinicians may use them in 2026 and beyond.

Together, the sessions set the tone for a meeting centered on connecting emerging evidence with everyday clinical decision-making.

Challenging Decisions in Cutaneous Oncology

Cutaneous oncology occupied a significant portion of the opening day's agenda, with a 2-part interactive update led by Rosen, Martin, Jennifer Lee, MD, and John Strasswimmer, MD, PhD.

Faculty addressed approaches spanning actinic keratoses through advanced nonmelanoma skin cancer and presented challenging cases designed to put attendees' clinical decision-making to the test. Participants used the meeting's survey app to select therapies before faculty discussed the reasoning behind their own treatment choices.

The second portion of the program continued with additional nonmelanoma skin cancer diagnostic and therapeutic dilemmas, reinforcing the meeting's emphasis on applying clinical evidence to situations clinicians may encounter in practice.

Working Through Difficult Dermatitis Cases

The afternoon continued with “Eczematous & Contact Dermatitis: ‘Cases That Will Leave You Scratching Your Head,’” featuring Zirwas; William Liszewski, MD; and Kachiu Lee Mudd, DMSc, MSPAS, PA-C.

Rather than relying solely on a traditional lecture format, faculty presented challenging eczematous conditions and asked attendees to determine how they would approach diagnosis and treatment. Participants again weighed in on therapeutic selections before faculty walked through their reasoning and clinical approach.

The session highlighted the complexity that can arise when similar clinical presentations require clinicians to work through broader differential diagnoses and treatment considerations.

Taking Procedural Skills Beyond the Basics

Day 1 concluded its CME programming with a practical focus during “Impractically Practical: Procedural Pearls,” led by David Oberlin, MD.

Designed for clinicians already comfortable with core dermatologic surgery, the session focused on high-yield procedural strategies intended to refine technique beyond the basics. Topics centered on nuanced tips, efficiency strategies, and technical refinements that clinicians can incorporate into everyday procedural practice.

The opening day concluded with a welcome reception, giving attendees an opportunity to connect before the meeting continued with another full slate of clinical programming on September 17.

  1. Yousif, R., Elgindi, D., & Paller, A. S. (2026). Systemic therapies for atopic dermatitis. Journal of the American Academy of Dermatology, 94(5S), S35–S42. https://doi.org/10.1016/j.jaad.2026.01.075
  2. Muñoz Couselo, E., Cañueto, J., Jerviz Guía, V., et al. (2025). Recommendations for the management of cutaneous squamous cell carcinoma: A systematic multidisciplinary Delphi consensus approach. Clinical and Translational Oncology, 27(7), 3058–3072. https://doi.org/10.1007/s12094-024-03826-5
  3. Pesqué, D., Aerts, O., Bizjak, M., et al. (2024). Differential diagnosis of contact dermatitis: A practical-approach review by the EADV Task Force on contact dermatitis. Journal of the European Academy of Dermatology and Venereology, 38(9), 1704–1722. https://doi.org/10.1111/jdv.20052

Related to this article